Science Explorer Back to mapMap
Discussion
Researcher · Phio Pharmaceuticals (United States) · United States

Dingxue Yan

Dingxue Yan publishes mostly in Molecular Biology, Oncology and Immunology, on topics such as CAR-T cell therapy research, RNA Interference and Gene Delivery and Immunotherapy and Immune Responses.

OpenAlex
World rank
#4,892,264
of 7,710,434 ranked researchers
Rank in United States
#1,276,357
of 1,627,098
Works
33
Citations
69
Citations per work
2.1
h-index
3
i10-index 1Top 99% in Molecular Biology
Dingxue Yan

What does Dingxue Yan research?

Dingxue Yan's work is mostly in Biochemistry, Genetics and Molecular Biology (38%), Medicine (28%), Immunology and Microbiology (16%).

Life Sciences: 18 works · 53.8% of their workBiochemistry, Genetics and Molecular Biology: 12 works · 37.7% of their workMolecular Biology: 12 works · 35.5% of their workBiotechnology: 1 works · 2.2% of their workImmunology and Microbiology: 5 works · 16.1% of their workImmunology: 5 works · 16.1% of their workHealth Sciences: 9 works · 28.0% of their workMedicine: 9 works · 28.0% of their workOncology: 7 works · 22.6% of their workRadiology, Nuclear Medicine and Imaging: 2 works · 5.4% of their workEverything else: 4 works · 11.7% of their workPhysical Sciences: 2 works · 6.5% of their workEngineering: 2 works · 6.5% of their workBiomedical Engineering: 2 works · 6.5% of their workTHEIR WORKDingxue Yan33works
Life Sciences54%Physical Sciences6%Health Sciences28%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1237.7%
    2. Immunology and Microbiology516.1%
    1. Medicine928.0%
  3. Everything else411.7%
    1. Engineering26.5%
  1. 1Molecular Biology36% of their works
  2. 2Oncology23% of their works
  3. 3Immunology16% of their works
  4. 4Biomedical Engineering6% of their works
  5. 5Radiology, Nuclear Medicine and Imaging5% of their works
  6. 6Biotechnology2% of their works

Research topics

Which keywords describe Dingxue Yan's research?

The keywords of their largest research topics: Cancer Immunotherapy, Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, RNA Interference, siRNA Delivery, Dendritic Cells and Immunity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Immunotherapy242 topics
  2. Immunotherapy192 topics
  3. CAR T Cells131 topic
  4. Chimeric Antigen Receptor131 topic
  5. RNA Interference121 topic
  6. siRNA Delivery121 topic
  7. Dendritic Cells111 topic
  8. Immunity111 topic
  9. BET Bromodomains81 topic
  10. PROTACs81 topic
  11. Nanoparticles61 topic
  12. Photothermal Therapy61 topic
  13. Fc Receptors51 topic
  14. Immune Checkpoint Blockade51 topic
  15. PD-1 and PD-L151 topic
  16. Therapeutic Antibodies51 topic
  17. HDAC Inhibitors41 topic
  18. Histone Deacetylases41 topic

Where does Dingxue Yan work?

Dingxue Yan's main affiliation in the publication record is Phio Pharmaceuticals (United States), United States.

How many publications and citations does Dingxue Yan have?

OpenAlex counts 33 works and 69 citations for Dingxue Yan, an h-index of 3, ranking #4,892,264 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Dingxue Yan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.